ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 123 filers reported holding ROYALTY PHARMA PLC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $138,080,000 | -46.5% | 3,464,990 | -51.5% | 12.96% | -14.3% |
| Q3 2021 | $258,143,000 | -11.8% | 7,142,856 | 0.0% | 15.13% | -10.2% |
| Q2 2021 | $292,786,000 | -37.4% | 7,142,856 | -33.3% | 16.85% | -35.5% |
| Q1 2021 | $467,357,000 | -36.4% | 10,714,284 | -27.1% | 26.11% | -34.5% |
| Q4 2020 | $735,274,000 | +19.0% | 14,690,780 | 0.0% | 39.88% | +17.3% |
| Q3 2020 | $618,041,000 | -13.3% | 14,690,780 | 0.0% | 33.99% | -44.1% |
| Q2 2020 | $713,237,000 | – | 14,690,780 | – | 60.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |